Dr. Reece - ASH 2008 - The Impact of Cytogenetics on the Outcomes of Treatment with Lenalidomide Plus Dexamethasone in Relapsed or Refractory Multiple Myeloma
Donna E. Reece, MD Princess Margaret Hospital Toronto, Ontario Canada Member, IMF Board of Scientific Advisors
back
print
related articles
Be the first to comment